Navigation Links
A new take on growth factor signaling in tamoxifen resistance
Date:6/23/2009

Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.

Sherene Loi, from the Peter MacCallum Cancer Centre, Melbourne, worked with a team of Australian and Belgian researchers to investigate the differences between those estrogen receptor positive (ER+) cancers that respond well to tamoxifen (luminal-A) and those that do not (luminal-B). She said, "This is the first study specifically investigating the biology of the luminal-B, ER+ breast cancer subtype. We propose that activation of GF signaling contributes to this highly proliferative, relatively tamoxifen-insensitive, phenotype and that this exists independently of HER2 overexpression. Targeting this pathway and its upstream mediators could prove to be a useful therapeutic strategy".

The researchers used a new computational method of analysis of gene expression data called gene set enrichment analysis (GSEA) to determine that there is increased growth factor activation from the gene expression profiles of nearly 100 luminal-B breast cancers samples. They then validated this finding by showing that treatment with the growth factor heregulin, which induced growth factor signaling an in-vitro model, could overcome tamoxifen-induced cell cycle arrest.

This research represents a departure from the informative, but sometimes not terribly useful, process of identifying genes associated with given conditions. Dr Loi said, "Although gene expression data has demonstrated its ability to identify subsets of disease and predict outcomes or drug responses, identifying new therapeutic approaches based on whole genome microarray profiling has, to date, been a significant challenge. By using GSEA, we've been able to use gene expression data to identify
'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-203-192-2165
BioMed Central
Source:Eurekalert

Page: 1 2

Related medicine news :

1. High pollution linked to poor lung function growth in children in Mexico City
2. Researchers develop long-lasting growth hormone
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
5. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
6. AWT Management Announce Aggressive Growth and Acquisition Strategy
7. Cynosure to Present at the Maxim Group Growth Conference
8. Human C-reactive protein regulates myeloma tumor cell growth and survival
9. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
10. Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference
11. Spectranetics to Present at The A.G Edwards Growth Conference on September 18

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...hat grew out of a collaboration between UCLA engin...o the nearly 10 million Americans who suffer from ... hardening of the arteries, peripheral arterial di...which narrowed arteries reduce blood flow to the l...ascular disease, heart attack and stroke, and its ...
(Date:11/25/2009)...as too short to draw definite conclusions, experts... News) -- In diabetic patients with blocked corona...outcomes at one year whether patients undergo bypa...esearchers report. , Bypass surgery has been th...ronary artery disease. However, less invasive appr...
(Date:11/25/2009)...aluation and treatment clinics to resume Monday, N...) November 25, 2009 -- Centegra Health System is c...ccine shots at four Centegra Primary Care (CPC) va...e has arrived. The clinics are at CPC sites in Hun... be open as follows: ,   From 4:30 to ...
(Date:11/25/2009)...eurological symptoms, study finds , , W... side effects are among the potential problems fac... were treated with cisplatin-based chemotherapy, a...9 Norwegian men treated for unilateral testicular ...llow-up survey conducted from 1998 to 2002. , T...
(Date:11/25/2009)...swire/-- MISSIONSkincare ®isproudtosupportGNC...ofGNC,sannualSt.Jude ThanksandGiving campaign,$1fr...SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Addition...10donationatcheckoutatoneoftheir5,000+retaillocati...St.Judeduringtheir2009 ThanksandGiving campaign. ,...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...ries is a threeat to the globe as 95% of the AIDS ...ral Assembly Special Session on HIV/AIDS, physicia...ral therapy that would cater the AIDS victims in d...SF provides healthcare assistance in 18 countries ...
...r of advertisements by the drug companies has prom...scription drug ads from television, news papers an...rsey delegate Dr. Angelo agro said that such ads c...that ads have tuned into a competition "to see who...
...as launched an oral treatment for smoking, called ...e) is reportedly the first product aimed at stoppi... Speaking to newspersons, Mr. Kalyanasundaram, Dir...Glaxo expects to target 50,000 patients which woul...
...st a nightmare to their respective parents, that t...ers identified three factors that may increase a c...m of the disease that does not respond to commonly...e at greatest risk, according to Anne Berg, an ass...
...ent disclosure revealed its truth when then Resear...Dr. Fernando D. Martinez According to Dr.Ferna...erweight or obese when they are between 6 and 11 y... researchers say. The risk of asthma is much ...
...ms to be the latest mantra of Pfizer. The pharmac...ee antifungal drug to 50 countries hardest hit by ...lose on the heels of the South African Government ...iven free of cost to battle HIV through a programe...
Other Medicine News:
(Date:11/25/2009)...landsandJOHANNESBURG,November25/PRNewswire/--,iThe...yannouncedtoday,thattheyhavesignedacollaborativeag..., Pyxis,sworldclasscomputationalchemistryandlead...cedivisiontoprovidemedicinaland,syntheticchemistry...onalclientnetwork.iThembaPharmaceuticalsandPyxisDi...
(Date:11/25/2009)...lif.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,annou...,sPROTECT-1(theProspectiveRandomizedOralTherapyEva...282-B)inpatientswithmoderate-to-severeCrohn,sdisea...andtolerabilityprofile.Thestudydemonstratedevidenc...asdefinedasa70-pointdecreaseintheCrohn,sDiseaseAct...
(Date:11/24/2009)...24/PRNewswire/-- ,, WHAT:RomHoubens,aBelgianman...cident,wasactuallyfullyconsciousandawakeduringthat...heDynaVoxEyeMaxwasfeaturedinthesegmenttoillustrate...nunlockcommunication. ,, WHEN:GoodMorningAmeric...navoxtech.com ,, WHO:RomHoubenswasanenginee...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Total Nonstop Action 28TNA 29 Wrestling Gets Energized with the Extreme Energy Shot 21 47998 1Total Nonstop Action 28TNA 29 Wrestling Gets Energized with the Extreme Energy Shot 21 47998 2NxStage to Present at the William Blair Growth Stock Conference 47994 1NxStage to Present at the William Blair Growth Stock Conference 47994 2Herb May Offer Hope for Autoimmune Diseases 47990 1Herb May Offer Hope for Autoimmune Diseases 47990 2Herb May Offer Hope for Autoimmune Diseases 47990 3
IDS Rapid One
Versatrek 240
Bax
Finstruments 404 Plate Washer
Medicine Products: